Background on Semaglutide and Compounding Pharmacies Semaglutide, a GLP-1 receptor agonist, is widely used for type 2 diabetes and weight loss under brand names like Ozempic and Wegovy
We discuss the critical importance of medication safety and patient safety, especially concerning prescription drugs.The discussion also touches upon a recent report of liver failure following the Foundayo launch, emphasizing the need for vigilant drug safety and thorough error analysis to prevent future incidents
Clinician insights on how to manage semaglutide-induced delayed gastric emptying and gastroparesis
Together, these discussions often leave people wondering what realistic weight loss results look like and whether their own experience is typical
CrossRef Circulating histones as potential biomarkers of MASLD-MASH-HCC progression Desislava K
In the gastrointestinal tract, the expression of GLP-1R in Bruner's gland of the duodenum has been detected ( Effect of GLP-1RAs on Inflammatory Response Induced by Sepsis In an observational study of patients with sepsis, it was found that endogenous GLP-1 was activated during sepsis, and GLP-1 levels were significantly elevated in patients with sepsis who died early (24 days post-admission) ( in vitro experiments of sepsis, GLP-1 analogs inhibited TNF and LPS-induced monocyte adhesion, thereby reducing vascular endothelial injury ( in vivo and in vitro ( Effect of GLP-1RAs on Immune Response Induced by Sepsis GLP-1R is expressed in macrophages, monocytes, B cells, and T cell lymphocytes